title: Liver transplantation at Yale-New Haven Transplantation Center.
abstract: It is possible to achieve better results after liver transplantation in adult and pediatric patients. An approach driven by multidisciplinary protocol is the most important factor, along with excellent communication skills, technical expertise, application of new technologies such as MARS and Arctic-Sun for ALF, and new knowledge/treatment protocols such as escalating-dose interferon ribavirin treatment, protocol biopsies, routine use of IL28B gene mutation and new protease inhibitors as part of antiviral therapy for hepatitis C.
authors: Yale-New Haven Transplantation Center, New Haven, Connecticut, USA. sukru.emre@yale.edu
authors: Sukru
authors: S
authors: Emre
authors: Manuel
authors: M
authors: Rodriguez-Davalos
authors: Veysel
authors: V
authors: Umman
authors: Katarzyna
authors: K
authors: Cartiera
authors: Sara
authors: S
authors: Wollwerth
authors: Lindsay
authors: L
authors: Arnott
authors: Antonios
authors: A
authors: Arvelakis
authors: Michael
authors: M
authors: Schilsky
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003237:Connecticut; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D008107:Liver Diseases / Q000209:etiology / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects / Q000276:immunology / Q000401:mortality; D019520:Living Donors / Q000600:supply & distribution; D008297:Male; D015397:Program Evaluation; D018570:Risk Assessment; D012307:Risk Factors; D016019:Survival Analysis; D013997:Time Factors; D014019:Tissue Donors / Q000600:supply & distribution*; D009927:Tissue and Organ Procurement; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents